T-cell based cancer immunotherapy: direct or redirected tumor-cell recognition?
- 31 January 1994
- journal article
- review article
- Published by Elsevier in Immunology Today
- Vol. 15 (1) , 11-15
- https://doi.org/10.1016/0167-5699(94)90019-1
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- Humanized antibodiesImmunology Today, 1993
- Lymphocyte interactions with endothelial cellsImmunology Today, 1992
- Naturally-occurring peptide antigens derived from the MHC class-I-restricted processing pathwayImmunology Today, 1991
- Icam ‐ melanoma cells are relatively resistant to cd3‐mediated t‐cell lysisInternational Journal of Cancer, 1990
- Role of the CD28 receptor in T-cell activationImmunology Today, 1990
- Inflammatory and immunomodulatory roles of TGF-βImmunology Today, 1989
- Systemic Reaction to the Anti–T-Cell Monoclonal Antibody OKT3 in Relation to Serum Levels of Tumor Necrosis Factor and Interferon-αNew England Journal of Medicine, 1989
- Oncogenes and Tumor-Suppressing GenesNew England Journal of Medicine, 1988
- Use of anti-receptor antibodies to focus T-cell activityImmunology Today, 1986
- Hybrid hybridomas and the production of bi-specific monoclonal antibodiesImmunology Today, 1984